Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311789849> ?p ?o ?g. }
- W4311789849 abstract "Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is associated with disorders affecting the peripheral and the central nervous system. A high number of patients develop post-COVID-19 syndrome with the persistence of a large spectrum of symptoms, including neurological, beyond 4 weeks after infection. Several potential mechanisms in the acute phase have been hypothesized, including damage of the blood-brain-barrier (BBB). We tested weather markers of BBB damage in association with markers of brain injury and systemic inflammation may help in identifying a blood signature for disease severity and neurological complications.Blood biomarkers of BBB disruption (MMP-9, GFAP), neuronal damage (NFL) and systemic inflammation (PPIA, IL-10, TNFα) were measured in two COVID-19 patient cohorts with high disease severity (ICUCovid; n=79) and with neurological complications (NeuroCovid; n=78), and in two control groups free from COVID-19 history, healthy subjects (n=20) and patients with amyotrophic lateral sclerosis (ALS; n=51). Samples from COVID-19 patients were collected during the first and the second wave of COVID-19 pandemic in Lombardy, Italy. Evaluations were done at acute and chronic phases of the COVID-19 infection.Blood biomarkers of BBB disruption and neuronal damage are high in COVID-19 patients with levels similar to or higher than ALS. NeuroCovid patients display lower levels of the cytokine storm inducer PPIA but higher levels of MMP-9 than ICUCovid patients. There was evidence of different temporal dynamics in ICUCovid compared to NeuroCovid patients with PPIA and IL-10 showing the highest levels in ICUCovid patients at acute phase. On the contrary, MMP-9 was higher at acute phase in NeuroCovid patients, with a severity dependency in the long-term. We also found a clear severity dependency of NFL and GFAP levels, with deceased patients showing the highest levels.The overall picture points to an increased risk for neurological complications in association with high levels of biomarkers of BBB disruption. Our observations may provide hints for therapeutic approaches mitigating BBB disruption to reduce the neurological damage in the acute phase and potential dysfunction in the long-term." @default.
- W4311789849 created "2022-12-28" @default.
- W4311789849 creator A5010578557 @default.
- W4311789849 creator A5011250436 @default.
- W4311789849 creator A5012963229 @default.
- W4311789849 creator A5022007793 @default.
- W4311789849 creator A5023473391 @default.
- W4311789849 creator A5025163046 @default.
- W4311789849 creator A5025424147 @default.
- W4311789849 creator A5026403490 @default.
- W4311789849 creator A5034940672 @default.
- W4311789849 creator A5037053264 @default.
- W4311789849 creator A5037473873 @default.
- W4311789849 creator A5041567751 @default.
- W4311789849 creator A5043805097 @default.
- W4311789849 creator A5046881595 @default.
- W4311789849 creator A5049549975 @default.
- W4311789849 creator A5050166878 @default.
- W4311789849 creator A5051402818 @default.
- W4311789849 creator A5055676801 @default.
- W4311789849 creator A5060876047 @default.
- W4311789849 creator A5064520148 @default.
- W4311789849 creator A5067201046 @default.
- W4311789849 creator A5069417319 @default.
- W4311789849 creator A5071587401 @default.
- W4311789849 creator A5071878678 @default.
- W4311789849 creator A5075552560 @default.
- W4311789849 creator A5075794623 @default.
- W4311789849 creator A5081493233 @default.
- W4311789849 creator A5082340666 @default.
- W4311789849 creator A5085521656 @default.
- W4311789849 date "2022-12-15" @default.
- W4311789849 modified "2023-10-17" @default.
- W4311789849 title "Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations" @default.
- W4311789849 cites W1496642521 @default.
- W4311789849 cites W1970593069 @default.
- W4311789849 cites W1979623506 @default.
- W4311789849 cites W1987751736 @default.
- W4311789849 cites W2005675003 @default.
- W4311789849 cites W2013392553 @default.
- W4311789849 cites W2023055347 @default.
- W4311789849 cites W2031762899 @default.
- W4311789849 cites W2036693329 @default.
- W4311789849 cites W2040706334 @default.
- W4311789849 cites W2074706709 @default.
- W4311789849 cites W2081710997 @default.
- W4311789849 cites W2103114977 @default.
- W4311789849 cites W2109323920 @default.
- W4311789849 cites W2116678262 @default.
- W4311789849 cites W2117691576 @default.
- W4311789849 cites W2127804398 @default.
- W4311789849 cites W2132076028 @default.
- W4311789849 cites W2163786444 @default.
- W4311789849 cites W2180292573 @default.
- W4311789849 cites W2255673114 @default.
- W4311789849 cites W2522152293 @default.
- W4311789849 cites W2552451940 @default.
- W4311789849 cites W2565276404 @default.
- W4311789849 cites W2624174582 @default.
- W4311789849 cites W2897165775 @default.
- W4311789849 cites W2919524616 @default.
- W4311789849 cites W2939789416 @default.
- W4311789849 cites W3001118548 @default.
- W4311789849 cites W3011825303 @default.
- W4311789849 cites W3023735120 @default.
- W4311789849 cites W3034678512 @default.
- W4311789849 cites W3035502447 @default.
- W4311789849 cites W3092444249 @default.
- W4311789849 cites W3107235131 @default.
- W4311789849 cites W3110367200 @default.
- W4311789849 cites W3114155216 @default.
- W4311789849 cites W3133814614 @default.
- W4311789849 cites W3139348872 @default.
- W4311789849 cites W3158285188 @default.
- W4311789849 cites W3161062707 @default.
- W4311789849 cites W3190487113 @default.
- W4311789849 cites W3193809569 @default.
- W4311789849 cites W3195559138 @default.
- W4311789849 cites W3196688992 @default.
- W4311789849 cites W3197462642 @default.
- W4311789849 cites W3203430312 @default.
- W4311789849 cites W3204727263 @default.
- W4311789849 cites W4200182658 @default.
- W4311789849 cites W4210242202 @default.
- W4311789849 cites W4213416459 @default.
- W4311789849 cites W4213447407 @default.
- W4311789849 cites W4220662180 @default.
- W4311789849 cites W4220692751 @default.
- W4311789849 cites W4223577665 @default.
- W4311789849 cites W4224029159 @default.
- W4311789849 cites W4226152276 @default.
- W4311789849 cites W4226365928 @default.
- W4311789849 cites W4283738986 @default.
- W4311789849 cites W4293455494 @default.
- W4311789849 cites W4293697921 @default.
- W4311789849 cites W4297463106 @default.
- W4311789849 doi "https://doi.org/10.3389/fimmu.2022.1070379" @default.
- W4311789849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36591311" @default.
- W4311789849 hasPublicationYear "2022" @default.
- W4311789849 type Work @default.